Provided by Tiger Trade Technology Pte. Ltd.

Crescent Biopharma Inc

17.15
+0.92005.67%
Post-market: 17.150.00000.00%19:30 EDT
Volume:218.39K
Turnover:3.65M
Market Cap:637.02M
PE:-2.31
High:17.19
Open:16.39
Low:16.03
Close:16.23
52wk High:27.41
52wk Low:8.72
Shares:37.14M
Float Shares:15.95M
Volume Ratio:1.33
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4105
EPS(LYR):-12.8150
ROE:-160.75%
ROA:-69.15%
PB:8.78
PE(LYR):-1.34

Loading ...

Mar 21, 2023

Major Issues Report

8-K - Current report
Mar 02, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 19, 2023

Major Issues Report

8-K - Current report
Jan 05, 2023

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 27, 2022

Major Issues Report

8-K - Current report
Dec 27, 2022

Business Combinations

425 - Prospectuses and communications, business combinations
Nov 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2022

Major Issues Report

8-K - Current report
Oct 07, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Sep 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 25, 2022

Major Issues Report

8-K - Current report
Aug 19, 2022

Major Issues Report

8-K - Current report
Aug 19, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 15, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 15, 2022

Major Issues Report

8-K - Current report
Aug 03, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership